Assessing the Clinical Influence of Chronic Total Occlusions (CTOs) Revascularization and the Impact of Vascularization Completeness on Patients with Left Ventricular (LV) Systolic Dysfunction

Table 4

Independent prediction factors of cardiac mortality and MACCE in all follow-up CTO patients.

	HR	95% CI	value
Cardiac mortality
3-vessel disease	1.072	0.309–3.722	0.913
Complete revascularization	0.777	0.299–2.019	0.605
Previous PCI	1.117	0.489–2.551	0.793
Previous MI	1.157	0.546–2.450	0.704
SCR	0.558	0.263–1.184	0.129
≧75 years of age	3.443	1.719–6.897	<0.001
MACCE
3-vessel disease	0.915	0.527–1.590	0.753
Complete revascularization	0.467	0.198–1.100	0.082
Previous PCI	1.592	1.034–2.449	0.035
Previous MI	1.971	1.258–3.088	0.003
SCR	0.499	0.320–0.776	0.002
≧75 years of age	1.343	0.832–2.167	0.227

Note. Data are expressed as numbers or proportions (%). Abbreviations. MACCE, major adverse cardiac and cerebrovascular events, a combination of ACD, cardiac mortality, relapse myocardium infarction, targeted vascular angiogenesis, rehospitalisation, cardiac failure, and stroke; PCI, percutaneous coronary intervention; MI, myocardial infarction; SCR, successful CTO revascularization.